PCR RT Market - Trends Forecast Till 2028

PCR/RT Market, Technology (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene expression, diagnostics), Enduser (Academia, pharma-biotech, applied) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: November, 2021

Base Year Estimate: 2020

Report ID: D-HC-PCRM-413

Format:  

Number of Pages: 273

Domain: Healthcare

PCR/RT Market – Trends Forecast Till 2028

The global PCR/RT market size is projected to reach USD 11.5 billion by 2026 at a CAGR of 6.7% from USD 7.5 billion in 2021 during the forecast period 2021-2028.

PCR or polymerase chain reaction is a widely used method for making multiple copies of a specific DNA sample. This is used in order to amplify the content of the desired segment of a DNA in a cell free medium. It was first invented in 1983 by Kary Mullis. The DNA polymerase enzyme used in the process is Taq polymerase as it is a thermostable polymerase.

With the surge in case of infectious disease and genetic disorders along with the recent development of PCR technologies and investments in the sector are some of the factors that have supported long-term expansion for PCR/RT Market.

The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. But the market of PCR/RT technology witnessed a boom during the pandemic as PCR is a standers test for gene sequencing and became an ideal tool for the lab testing for COVID-19

PCR Market Analysis

Asia Pacific is expected to be the largest market during the forecast period. The advancement in the healthcare system along with the increased research and development in the sector have led to growth in the PCR technology in the region.

PCR/RT Market is segmented into Technique, Product, Application, End User and geography.

On the basis of Technique

  • Conventional PCR
    • Real-time PCR (qPCR)
    • Digital PCR (dPCR)
    • Reverse Transcription PCR (RT-PCR)
    • Hot-start PCR
    • Multiplex PCR
    • Other PCR

On the basis of End-User

  • Hospitals and diagnostic labs
  • Healthcare industry
  • Academia and government organizations
  • Pharma-biotech companies
  • Applied industries
  • Other end users

On the basis of Application

  • Gene expression analysis
    • Genetic sequencing
    • Genotyping
    • Nucleic acid detection
    • Nucleic acid synthesis
    • Standard validation/verification
    • Diagnostic Applications
    • Environmental Applications
    • Other Applications

On the basis of Product

  • Instruments
    • Reagents and consumables
    • Software and services

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

PCR Market Primary Respondents

 

Key Players

  • Thermo Fisher Scientific, Inc
  • F. Hoffman-La Roche Ltd
  • Bio-Rad Laboratories, Inc
  • QIAGEN N.V.
  • Takara Bio, Inc.
  • Agilent Technologies, Inc.
  • bioMérieux S.A.
  • Fluidigm Corporatio
  • Danaher Corporation
  • Abbott Laboratories
  • Merck KGaA
  • Becton Dickinson and Compan
  • Promega Corporation
  • Eppendorf AG
  • Analytik Jena AG

Recent Developments

  • In 2020, FDA 510(k) clearance was given to Roche for the cobas BKV Test on the cobas 6800 and 8800 Systems
  • In 2020, Roche’s cobas SARS-CoV-2 & Influenza A/B Test received emergency use authorization for use on the cobas 6800/8800 Systems from the FDA

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for PCR/RT market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 7.5 billion

Growth Rate

CAGR of 6.7% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD million and CAGR from 2021 to 2028

Report Segmentation

Technique, Product, Application, End User and geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Takara Bio, Inc., Agilent Technologies, Inc., bioMérieux S.A., Fluidigm Corporation, Danaher Corporation, Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Promega Corporation, Eppendorf AG, and Analytik Jena AG

Available Customization

In addition to the market data for PCR/RT Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.